University of South Florida - Byrd Alzheimer's Institute
Welcome,         Profile    Billing    Logout  
 10 Trials 
6 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Smith, Amanda
REFOCUS-ALZ, NCT05026177: Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease

Terminated
3
1125
Canada, US, RoW
Simufilam, PTI-125, Placebo
Cassava Sciences, Inc., Premier Research Group plc
Alzheimer Disease
12/24
12/24
ENVISION, NCT05310071 / 2022-001671-14: A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

Terminated
3
1027
Europe, Canada, Japan, US, RoW
Aducanumab, BIIB037, Aducanumab-avwa, Aduhelm, Placebo
Biogen, Biogen Idec Research Limited
Alzheimer's Disease
08/24
08/24
Spectra, NCT05393284: Phase 2 Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy

Active, not recruiting
2
114
US
OPL-0401 Dose 1, Placebo
Valo Health, Inc.
Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy
08/24
08/24
MAGIC, NCT05681884: Safety and Efficacy of Faricimab in Patients With NPDR

Active, not recruiting
2
179
US
Faricimab
Greater Houston Retina Research, Genentech, Inc.
Non-Proliferative Diabetic Retinopathy
03/26
04/26
NCT05715346: LEV102 Topical Gel in Acquired Blepharoptosis

Completed
1/2
33
US
LEV102 1.0%, LEV102 2.0%, Vehicle
Levation Pharma, Ltd.
Acquired Blepharoptosis
06/23
06/23
i-GAIN, NCT05797896: Investigating Geographic Atrophy Insights () Natural History Study

Recruiting
N/A
250
Europe, US
Complement Therapeutics
Dry Age-related Macular Degeneration, Geographic Atrophy, Retinal Disease, Macular Degeneration, Macular Atrophy, Retinal Degeneration, Eye Diseases
12/26
12/26
Raj, Balebail A
No trials found
Janavs, Juris
No trials found
Flynn, Myrna DeJesus
No trials found
Rodrigo, Kelly
No trials found
Ettelson, David
No trials found
Major, Beth
No trials found

Download Options